(Q42617736)

English

The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients

scientific article published on 3 April 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients (English)

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

author name string

Kuvaja Paula

1

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Talvensaari-Mattila Anne

2

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Turpeenniemi-Hujanen Taina

3

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

publication date

3 April 2007

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Biomarker Insights

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

2

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

117-127

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

27 May 2018

Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

27 May 2018

Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

27 May 2018

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

27 May 2018

The effect of EDTA contaminated in sera on laboratory data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

27 May 2018

How matrix metalloproteinases regulate cell behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

27 May 2018

Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

16 August 2018

Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

16 August 2018

Preoperative serum MMP-9 immunoreactive protein is a prognostic indicator for relapse-free survival in breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

16 August 2018

Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

16 August 2018

Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717846

16 August 2018

Release of gelatinase A during platelet activation mediates aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High preoperative serum TIMP-1 is a prognostic indicator for survival in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum or plasma: What kind of blood sample should be used to measure circulating matrix metalloproteinases and their inhibitors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of anticoagulants and cell separation media as preanalytical determinants on zymographic analysis of plasma matrix metalloproteinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of blood collection methods on gelatin zymography of matrix metalloproteinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19662197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42617736&oldid=1962890406"